The information collection supports
the filing of certain citizen petitions and agency guidance. The
guidance describes how FDA will determine whether the provisions of
section 505(q) addressing the treatment of citizen petitions and
petitions for stay of agency action (collectively, petitions) apply
to a particular petition and whether a petition would delay
approval of a pending abbreviate new drug application or a
505(b)(2) application. The guidance also describes the provisions
of section 505(q) requiring that a petition include a certification
and that supplemental information or comments to a petition include
a verification.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.